Details of the Drug

General Information of Drug (ID: DM6VA14)

Drug Name

AK-106-001616

Indication

Disease Entry	ICD 11	Status	REF
Rheumatoid arthritis	FA20	Phase 2	[1]
------------------------------------------------------------------------------------

Cross-matching ID

References

1	ClinicalTrials.gov (NCT00902369) A Study of AK106-001616 in Patients With Rheumatoid Arthritis (RA). U.S. National Institutes of Health.